Dietary (n-3) polyunsaturated fatty acids affect the kinetics of pro- and antiinflammatory responses in mice with Pseudomonas aeruginosa lung infection.

The underlying mechanisms by which eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) affect host resistance to Pseudomonas aeruginosa are unclear. The aim of this study was to determine their role on the kinetic of pro- and antiinflammatory response in lung infection. Mice fed either a control diet or a diet enriched with EPA and DHA were infected intratracheally and we studied lung expression of proinflammatory markers [CXCL1, interleukin (IL)-6, tumor necrosis factor-alpha], antiinflammatory markers (IL-10, A20, and IkappaB alpha), and PPARalpha and PPARgamma. The inflammatory response was assessed using recruitment of neutrophils and macrophages into bronchoalveolar lavage fluid, bacterial clearance from the lung, pulmonary injury, and 7-d survival rate. Compared with the control group, EPA and DHA delayed the expression of proinflammatory markers during the first 2 h (P < 0.05), upregulated proinflammatory marker expression (P < 0.05), and induced overexpression of antiinflammatory markers at 8 h (P < 0.05), enhanced recruitment of neutrophils at 16 h (P < 0.05), and induced PPARalpha and PPARgamma overexpression at 4 and 8 h (P < 0.01), respectively. Pulmonary bacterial load decreased and pulmonary injury and mortality were reduced during the first 24 h (P < 0.05). In conclusion, EPA and DHA modulate the balance between pro- and antiinflammatory cytokines, alter the early response of the host to P. aeruginosa infection, and affect the early outcome of infection.

[1]  P. Calder Immunomodulation by omega-3 fatty acids. , 2007, Prostaglandins, leukotrienes, and essential fatty acids.

[2]  S. Sert,et al.  Liver lipid peroxidation in experimental Escherichia coli peritonitis: the role of myeloperoxidase and nitric oxide inhibition. , 2007, Medical science monitor : international medical journal of experimental and clinical research.

[3]  C. Glass,et al.  PPARs and molecular mechanisms of transrepression. , 2007, Biochimica et biophysica acta.

[4]  F. Gottrand,et al.  Dietary n-3 fatty acids have suppressive effects on mucin upregulation in mice infected with Pseudomonas aeruginosa , 2007, Respiratory research.

[5]  H. Bujo,et al.  Effect of PPARalpha activation of macrophages on the secretion of inflammatory cytokines in cultured adipocytes. , 2007, European journal of pharmacology.

[6]  H. Roche,et al.  Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid. , 2007, The Journal of nutritional biochemistry.

[7]  F. Gottrand,et al.  Omega-3 polyunsaturated fatty acids improve host response in chronic Pseudomonas aeruginosa lung infection in mice. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[8]  B. Brüne,et al.  Peroxisome proliferator-activated receptor γ (PPARγ) and sepsis , 2007, Archivum Immunologiae et Therapiae Experimentalis.

[9]  S. Akira,et al.  The myeloid differentiation factor 88 is dispensable for the development of a delayed host response to Pseudomonas aeruginosa lung infection in mice , 2006, Clinical and experimental immunology.

[10]  A. Simopoulos Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. , 2006, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[11]  C. Ferran,et al.  A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasia , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  T. Buclin,et al.  Biological effects of a dietary omega-3 polyunsaturated fatty acids supplementation in cystic fibrosis patients: a randomized, crossover placebo-controlled trial. , 2006, Clinical nutrition.

[13]  P. Calder n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. , 2006, The American journal of clinical nutrition.

[14]  E. Mazzon,et al.  The role of the peroxisome proliferator‐activated receptor‐α (PPAR‐α) in the regulation of acute inflammation , 2006 .

[15]  F. Gottrand,et al.  Long-Chain Polyunsaturated Fatty Acids Modulate Lung Inflammatory Response Induced by Pseudomonas aeruginosa in Mice , 2005, Pediatric Research.

[16]  Richard A. Young,et al.  Insights into host responses against pathogens from transcriptional profiling , 2005, Nature Reviews Microbiology.

[17]  Z. Varghese,et al.  EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism. , 2005, Kidney international.

[18]  R. Chapkin,et al.  Dietary Docosahexaenoic Acid Suppresses T Cell Protein Kinase Cθ Lipid Raft Recruitment and IL-2 Production1 , 2004, The Journal of Immunology.

[19]  C. Pham,et al.  NF-κB and JNK: An Intricate Affair , 2004 .

[20]  K. Leslie,et al.  Identification of a novel mechanism of NF-kappaB inactivation by progesterone through progesterone receptors in Hec50co poorly differentiated endometrial cancer cells: induction of A20 and ABIN-2. , 2004, Gynecologic oncology.

[21]  J. Goust,et al.  The Effects of Calpain Inhibition on IkBα Degradation After Activation of PBMCs: Identification of the Calpain Cleavage Sites , 2004, Neurochemical Research.

[22]  V. Keshamouni,et al.  Deactivation of murine alveolar macrophages by peroxisome proliferator-activated receptor-gamma ligands. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[23]  M. De la Fuente,et al.  Immune cells: free radicals and antioxidants in sepsis. , 2004, International immunopharmacology.

[24]  S. Wassall,et al.  Docosahexaenoic acid: membrane properties of a unique fatty acid. , 2003, Chemistry and physics of lipids.

[25]  N. Sizemore,et al.  Reciprocal Modulation of Toll-like Receptor-4 Signaling Pathways Involving MyD88 and Phosphatidylinositol 3-Kinase/AKT by Saturated and Polyunsaturated Fatty Acids* , 2003, Journal of Biological Chemistry.

[26]  V. Cherezov,et al.  Interaction of cholesterol with a docosahexaenoic acid-containing phosphatidylethanolamine: trigger for microdomain/raft formation? , 2003, Biochemistry.

[27]  R. Chapkin,et al.  Dietary (n-3) polyunsaturated fatty acids remodel mouse T-cell lipid rafts. , 2003, The Journal of nutrition.

[28]  D. Hwang,et al.  Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. , 2003, Journal of lipid research.

[29]  A. Simopoulos Omega-3 Fatty Acids in Inflammation and Autoimmune Diseases , 2002, Journal of the American College of Nutrition.

[30]  K. Fritsche,et al.  (n-3) Fatty acids and infectious disease resistance. , 2002, The Journal of nutrition.

[31]  J. Davies,et al.  Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence. , 2002, Paediatric respiratory reviews.

[32]  M. Laville,et al.  Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma. , 2002, Obesity research.

[33]  J. Morrow,et al.  Characterization of LPS-induced lung inflammation in cftr-/- mice and the effect of docosahexaenoic acid. , 2002, Journal of applied physiology.

[34]  P. Calder,et al.  Fatty acids and lymphocyte functions , 2002, British Journal of Nutrition.

[35]  W. Waldhäusl,et al.  Polyunsaturated Eicosapentaenoic Acid Displaces Proteins from Membrane Rafts by Altering Raft Lipid Composition* , 2001, The Journal of Biological Chemistry.

[36]  D. Wakefield,et al.  The role of IL-1ß in the regulation of IL-8 and IL-6 in human corneal epithelial cells during Pseudomonas aeruginosa colonization , 2001, Current eye research.

[37]  B. Staels,et al.  Induction of IκBα Expression as a Mechanism Contributing to the Anti-inflammatory Activities of Peroxisome Proliferator-activated Receptor-α Activators* , 2000, The Journal of Biological Chemistry.

[38]  P. G. Reeves Components of the AIN-93 diets as improvements in the AIN-76A diet. , 1997, The Journal of nutrition.

[39]  M. D. Leibowitz,et al.  Molecular Cloning, Expression and Characterization of Human Peroxisome Proliferator Activated Receptors γ1 and γ2 , 1996 .

[40]  J. Dipiro,et al.  Interleukin-10 is associated with the development of sepsis in trauma patients. , 1996, The Journal of trauma.

[41]  E. Collie-Duguid,et al.  Inhibitory effect of fish oil N-3 polyunsaturated fatty acids on the expression of endothelial cell adhesion molecules. , 1996, Biochemical and biophysical research communications.

[42]  D. Noonan,et al.  Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[43]  R. Colvin,et al.  Suppression of autoimmune disease by dietary n-3 fatty acids. , 1993, Journal of lipid research.

[44]  O. Mcbride,et al.  cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. , 1993, Biochemistry.

[45]  R. Chapkin,et al.  5-series peptido-leukotriene synthesis in mouse peritoneal macrophages: modulation by dietary n-3 fatty acids. , 1990, Biochemical and biophysical research communications.

[46]  J. Alexander,et al.  The effect of dietary fatty acids on response to Pseudomonas infection in burned mice. , 1990, The Journal of trauma.

[47]  B. Brüne,et al.  Peroxisome proliferator-activated receptor gamma (PPAR gamma) and sepsis. , 2007, Archivum immunologiae et therapiae experimentalis.

[48]  E. Mazzon,et al.  The role of the peroxisome proliferator-activated receptor-alpha (PPAR-alpha) in the regulation of acute inflammation. , 2006, Journal of leukocyte biology.

[49]  L. Cleland,et al.  Biological activity of prostaglandin E3 with regard to oedema formation in mice , 2005, Agents and Actions.

[50]  C. Pham,et al.  NF-kappaB and JNK: an intricate affair. , 2004, Cell cycle.

[51]  B. Staels,et al.  Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators. , 2000, The Journal of biological chemistry.

[52]  M. D. Leibowitz,et al.  Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. , 1996, Biochemical and biophysical research communications.

[53]  J. Kinsella,et al.  In vivo formation of leukotriene E5 by murine peritoneal cells. , 1991, Prostaglandins.